Literature DB >> 16636138

Parametric regression on cumulative incidence function.

Jong-Hyeon Jeong1, Jason P Fine.   

Abstract

We propose parametric regression analysis of cumulative incidence function with competing risks data. A simple form of Gompertz distribution is used for the improper baseline subdistribution of the event of interest. Maximum likelihood inferences on regression parameters and associated cumulative incidence function are developed for parametric models, including a flexible generalized odds rate model. Estimation of the long-term proportion of patients with cause-specific events is straightforward in the parametric setting. Simple goodness-of-fit tests are discussed for evaluating a fixed odds rate assumption. The parametric regression methods are compared with an existing semiparametric regression analysis on a breast cancer data set where the cumulative incidence of recurrence is of interest. The results demonstrate that the likelihood-based parametric analyses for the cumulative incidence function are a practically useful alternative to the semiparametric analyses.

Entities:  

Mesh:

Year:  2006        PMID: 16636138     DOI: 10.1093/biostatistics/kxj040

Source DB:  PubMed          Journal:  Biostatistics        ISSN: 1465-4644            Impact factor:   5.899


  27 in total

1.  The use and interpretation of competing risks regression models.

Authors:  James J Dignam; Qiang Zhang; Masha Kocherginsky
Journal:  Clin Cancer Res       Date:  2012-01-26       Impact factor: 12.531

2.  Baseline age and time to major fracture in younger postmenopausal women.

Authors:  Margaret Lee Gourlay; Robert A Overman; Jason P Fine; Kristine E Ensrud; Carolyn J Crandall; Margery L Gass; John Robbins; Karen C Johnson; Erin S LeBlanc; Catherine R Womack; John T Schousboe; Andrea Z LaCroix
Journal:  Menopause       Date:  2015-06       Impact factor: 2.953

3.  Time to Clinically Relevant Fracture Risk Scores in Postmenopausal Women.

Authors:  Margaret L Gourlay; Robert A Overman; Jason P Fine; Carolyn J Crandall; John Robbins; John T Schousboe; Kristine E Ensrud; Erin S LeBlanc; Margery L Gass; Karen C Johnson; Catherine R Womack; Andrea Z LaCroix
Journal:  Am J Med       Date:  2017-03-09       Impact factor: 4.965

4.  Semiparametric competing risks regression under interval censoring using the R package intccr.

Authors:  Jun Park; Giorgos Bakoyannis; Constantin T Yiannoutsos
Journal:  Comput Methods Programs Biomed       Date:  2019-03-08       Impact factor: 5.428

5.  Semiparametric regression on cumulative incidence function with interval-censored competing risks data.

Authors:  Giorgos Bakoyannis; Menggang Yu; Constantin T Yiannoutsos
Journal:  Stat Med       Date:  2017-06-12       Impact factor: 2.373

6.  Impact of race on survival in patients with clinically nonmetastatic prostate cancer who deferred primary treatment.

Authors:  Michael Koscuiszka; David Hatcher; Paul J Christos; Amy E Rose; Holly S Greenwald; Ya-lin Chiu; Samir S Taneja; Madhu Mazumdar; Peng Lee; Iman Osman
Journal:  Cancer       Date:  2011-10-21       Impact factor: 6.860

7.  Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus trastuzumab as adjuvant therapy for patients with node-positive, human epidermal growth factor receptor 2-positive breast cancer.

Authors:  Edward H Romond; Jong-Hyeon Jeong; Priya Rastogi; Sandra M Swain; Charles E Geyer; Michael S Ewer; Vikas Rathi; Louis Fehrenbacher; Adam Brufsky; Catherine A Azar; Patrick J Flynn; John L Zapas; Jonathan Polikoff; Howard M Gross; David D Biggs; James N Atkins; Elizabeth Tan-Chiu; Ping Zheng; Greg Yothers; Eleftherios P Mamounas; Norman Wolmark
Journal:  J Clin Oncol       Date:  2012-09-17       Impact factor: 44.544

8.  Comparing competing risk outcomes within principal strata, with application to studies of mother-to-child transmission of HIV.

Authors:  Dustin M Long; Michael G Hudgens
Journal:  Stat Med       Date:  2012-08-28       Impact factor: 2.373

9.  Choice and interpretation of statistical tests used when competing risks are present.

Authors:  James J Dignam; Maria N Kocherginsky
Journal:  J Clin Oncol       Date:  2008-08-20       Impact factor: 44.544

10.  Direct likelihood inference on the cause-specific cumulative incidence function: A flexible parametric regression modelling approach.

Authors:  Sarwar Islam Mozumder; Mark Rutherford; Paul Lambert
Journal:  Stat Med       Date:  2017-10-02       Impact factor: 2.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.